Clinical Trial Update: Effects of a Supplement Derived From Palm Oil on Cholesterol Levels and Chinese Red Yeast Rice in the Blood [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial investigating a palm-oil-derived supplement and Chinese red yeast rice for cholesterol lowering was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholesterol Lowering
• Hyperlipidemia

Drugs mentioned

• Chinese red yeast rice (Monacolin K-containing product)
• Supplement derived from palm oil

Snippet

Sponsor: University of California, Los Angeles | Conditions: Cholesterol Lowering | Phase 2, Phase 3 | Status: WITHDRAWN